Gut microbiota diversity repeatedly diminishes over time following maintenance infliximab infusions in paediatric IBD patients.
<h4>Background</h4>The gut microbiome plays a crucial role in the pathogenesis and progression of inflammatory bowel disease (IBD). Understanding the dynamics of the gut microbiome in relation to treatment can provide valuable insights into disease management and therapy strategies. The...
Saved in:
| Main Authors: | , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2024-01-01
|
| Series: | PLoS ONE |
| Online Access: | https://doi.org/10.1371/journal.pone.0311604 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|